首页> 外文OA文献 >COPII vesicles derived from mammalian endoplasmic reticulum microsomes recruit COPI
【2h】

COPII vesicles derived from mammalian endoplasmic reticulum microsomes recruit COPI

机译:来源于哺乳动物内质网微粒体的COPII囊泡 招募COPI

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ER to Golgi transport requires the function of two distinct vesicle coat complexes, termed COPI (coatomer) and COPII, whose assembly is regulated by the small GTPases ADP-ribosylation factor 1 (ARF1) and Sar1, respectively. To address their individual roles in transport, we have developed a new assay using mammalian microsomes that reconstitute the formation of ER-derived vesicular carriers. Vesicles released from the ER were found to contain the cargo molecule vesicular stomatitis virus glycoprotein (VSV-G) and p58, an endogenous protein that continuously recycles between the ER and pre-Golgi intermediates. Cargo was efficiently sorted from resident ER proteins during vesicle formation in vitro. Export of VSV-G and p58 were found to be exclusively mediated by COPII. Subsequent movement of ER-derived carriers to the Golgi stack was blocked by a trans-dominant ARF1 mutant restricted to the GDP-bound state, which is known to prevent COPI recruitment. To establish the initial site of coatomer assembly after export from the ER, we immunoisolated the vesicular intermediates and tested their ability to recruit COPI. Vesicles bound coatomer in a physiological fashion requiring an ARF1-guanine nucleotide exchange activity. These results suggest that coat exchange is an early event preceding the targeting of ER-derived vesicles to pre-Golgi intermediates.
机译:ER向高尔基体的转运需要两种不同的囊泡被膜复合物的功能,分别称为COPI(被膜)和COPII,它们的组装分别由小的GTPases ADP-核糖基化因子1(ARF1)和Sar1调节。为了解决它们在运输中的作用,我们开发了一种新的测定方法,使用了哺乳动物微粒体来重构ER来源的囊泡载体的形成。发现从ER释放的囊泡中包含货物分子水泡性口炎病毒糖蛋白(VSV-G)和p58,p58是一种在ER和高尔基前体中间体之间连续循环的内源性蛋白质。在体外囊泡形成过程中,从驻留的ER蛋白有效地分选了货物。发现VSV-G和p58的输出完全由COPII介导。 ER来源的携带者随后向高尔基体的移动被限制在GDP结合状态的反式ARF1突变体所阻止,该突变体已知会阻止COPI募集。为了建立从ER出口后涂层剂组装的初始位点,我们免疫分离了水泡中间体,并测试了其募集COPI的能力。囊泡以需要ARF1-鸟嘌呤核苷酸交换活性的生理学方式结合了涂层剂。这些结果表明,在将ER来源的囊泡靶向高尔基之前的中间体之前,皮毛交换是一个早期事件。

著录项

  • 作者

  • 作者单位
  • 年度 1996
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号